Lebellec, L., Bertucci, F., Tresch-Bruneel, E., Ray-Coquard, I., Le Cesne, A., Bompas, E., . . . Le Deley, M. (2018). Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: An ancillary study derived from a randomized clinical trial. BMC Cancer.
Dyfyniad Arddull ChicagoLebellec, Loïc, et al. "Prognostic and Predictive Factors for Angiosarcoma Patients Receiving Paclitaxel Once Weekly Plus or Minus Bevacizumab: An Ancillary Study Derived From a Randomized Clinical Trial." BMC Cancer 2018.
Dyfyniad MLALebellec, Loïc, et al. "Prognostic and Predictive Factors for Angiosarcoma Patients Receiving Paclitaxel Once Weekly Plus or Minus Bevacizumab: An Ancillary Study Derived From a Randomized Clinical Trial." BMC Cancer 2018.